ArticleQuantitative imaging in medicine and surgery2025
Pipeline embolization device versus Neuroform Atlas stent in the treatment of distal anterior circulation aneurysms: a retrospective cohort study.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endovascular therapy is increasingly being employed in the management of distal anterior circulation aneurysms (DACAs). However, studies directly comparing the efficacy and safety of pipeline embolization devices (PEDs) and Atlas stent-assisted coiling (SAC) in the treatment of DACAs remain limited. This study aimed to compare the two endovascular treatment strategies in terms of the clinical outcomes, angiographic results, and hospital costs. Methods: Consecutive DACA patients treated at two neurosurgical centers with either the PED or Atlas SAC were studied. The angiographic and clinical outcomes, procedure details, and hospital costs of the two devices were compared. A multivariate logistic regression analysis was performed to identify the predictors of incomplete aneurysm occlusion. Results: A total of 112 consecutive patients with 114 DACAs were enrolled in the study, of whom 51 were treated with PED and 63 with Atlas SAC. The PED group had a significantly higher stent adjustment rate than the Atlas group (7.8% Conclusions: The PED and Atlas SAC are equally safe and effective in the treatment of DACAs. The PED has the advantage of a shorter operation time, while Atlas SAC is more cost-effective. The presence of an incorporated branch is an independent predictor of delayed aneurysm occlusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.